Abstracts (HTML) List of Authors

Baars, T

Ultrasound diagnosis of hepatic steatosis represents increased metabolic risk

Baba, H

Postmortal diagnosis of hemophagocytic lymphohistiocytosis in a patient with liver failure of unknown etiology

Baba, HA

Ultrasound diagnosis of hepatic steatosis represents increased metabolic risk
Differentiated Liver Damage by Acetaminophen in a Human Ex-Vivo Liver Model
Annexin A10 meets the challenge of differentiating intrahepatic cholangiocarcinoma from metastatic pancreatic ductal adenocarcinoma. A comparative study of immunohistochemical markers
Hepatic expression of oncogenes Bmi1 and Dkk1 is up-regulated in hepatitis B virus surface antigen-transgenic mice in vivo and can be induced by treatment with HBV particles or lipopolysaccharides in vitro

Bachmann, H

Der SNP3099 im mTOR Gen ist prädiktiv für die Verträglichkeit und Wirkung von Everolimus nach Lebertransplantation

Baier, K

Modulation der Unfolded Protein Response (UPR) im murinen HBV-Modell durch Aktivierung des Transkriptionsfaktors ATF6

Ball, C

Distinct transcriptome and secretome patterns characterize capillarization in early and late phases of hepatocarcinogenesis

Bangen, JM

Differentiation and effects of TGF-β1 and IL-3 signaling on primary murine endoglin deficient mast cells

Bankwitz, D

Extracellular maturation of secreted hepatitis C virus particles by incorporation of Apoliporotein E enhances infectivity

Bantel, H

Serum Cell Death Biomarker Mirrors Liver Cancer Regression after Transarterial Chemoembolisation
The lack of the organic cation transporter OCT1 at the plasma membrane of tumor cells precludes a positive response to sorafenib in patients with hepatocellular carcinoma
Lack of Polarity in liver progenitor cell-derived hepatocytes determines poor clinical outcome of acute-on-chronic liver failure
Presence of the MBOAT7 rs641738 variant might enhance liver fibrosis in patients with fatty liver: analysis of the German NAFLD CSG cohort

Barikbin, R

The Role of IFNγ in the Immune Pathogenesis of Primary Sclerosing Cholangitis
Inflammation and Fibrosis in the Livers of TNFR1/Mdr2ko Mice

Bartsch, DK

Hypoxia causes hepatic stellate cells activation in the absence of CUX1
Cux1 confers resistance to apoptotic cell death in liver cancer cells
CUX1 controls endoplasmic reticulum stress and autophagy related cell death

Bartsch, H

Carcinogenic Etheno DNA-Adducts in Alcoholic Liver Disease: Correlation with Cytochrome P-450 and Fibrosis

Baues, J

Role of the IQGAP1/IQGAP2 imbalance in Liver Cancer

Bechmann, L

Fibrosis in adipose tissue is correlated to liver injury in NAFLD
Thyroid Hormone Receptor (TR): a regulator in Liver Fibrogenesis
Postmortal diagnosis of hemophagocytic lymphohistiocytosis in a patient with liver failure of unknown etiology

Bechmann, LP

A non-invasive comparison between NASH and Crohn's disease
Ultrasound diagnosis of hepatic steatosis represents increased metabolic risk
Hepatocyte KLF6 regulates autophagy in a p53 dependent manner

Becker, D

Activation of tumor initiating cells during anti-angiogenic therapies promotes tumor progression and relapse formation in hepatocellular carcinoma

Becker, E

Hypoxia causes hepatic stellate cells activation in the absence of CUX1

Bedreli, S

3 Jahre Real-Life Essener Erfahrungen einer Everolimus-basierten Immunsuppression nach Lebertransplantation
Evaluation eines Faktor XIII-Mangels mittels Rotationsthrombelastometrie (ROTEM®) bei Leberzirrhosepatienten mit Blutungsneigung
Der SNP3099 im mTOR Gen ist prädiktiv für die Verträglichkeit und Wirkung von Everolimus nach Lebertransplantation

Behrmann, I

Cytokines and hepatocellular carcinoma: Potential progression markers and cell typespecific modulators of the mirnome (Interleukin-6 and JAK/STAT activating cytokines)
Evaluation der pro-steatotischen Genvariante rs641738 im MBOAT7-Gen bei Patienten mit hepatozellulärem Karzinom (HCC)

Beine, B

Lipocalin 2 (LCN2)-deficient mice are more prone to hepatic steatosis: LCN2 and mitochondrial and peroxisomal integrity

Belahmer, H

Loss of APC/CDH1 confers sensitivity to synthetic endoplasmatic reticulum stress through the dysregulation of GADD34

Benkö, T

Differentiated Liver Damage by Acetaminophen in a Human Ex-Vivo Liver Model

Benz, F

Evaluation der Serumkonzentration von Osteopontin als diagnostischer und prognostischer Biomarker in Patienten mit cholangiozellulärem Karzinom

Berg, CP

Cholestasis is associated with induction of antimicrobial active reduced human β-defensin 1

Berg, T

Association of Toll-like receptor 4 (TLR4) gene polymorphisms with remission of chronic hepatitis B infections in female patients
Single Nucleotide Polymorphisms (SNPs) im Scarb1 Gen und deren Bedeutung für eine Hepatitis C Virus Infektion

Berger, T

Lipocalin 2 (LCN2)-deficient mice are more prone to hepatic steatosis: LCN2 and mitochondrial and peroxisomal integrity

Bergheim, I

Iso-Alpha Acids (IAA) from hops (Humulus lupulus) inhibit hepatic steatosis, inflammation and fibrosis

Berkhout, L

Inflammation and Fibrosis in the Livers of TNFR1/Mdr2ko Mice
Gut Microbiota as a Target in T cell- mediated hepatic Injury

Berres, ML

Th2-polarization of CD4+ T-cells is locally induced and drives liver fibrogenesis

Bertram, S

Annexin A10 meets the challenge of differentiating intrahepatic cholangiocarcinoma from metastatic pancreatic ductal adenocarcinoma. A comparative study of immunohistochemical markers

Best, J

Hepatocyte KLF6 regulates autophagy in a p53 dependent manner
Predictors of Longer Survival after Radioembolization in Unilobar and Bilobar Advanced Hepatocellular Carcinoma with Yttrium-90
C-Reactive Protein the Best Survival Predictor in 100 HCCs with Portal Vein Thrombosis after Radioembolization with Yttrium-90

Bettinger, D

The lack of the organic cation transporter OCT1 at the plasma membrane of tumor cells precludes a positive response to sorafenib in patients with hepatocellular carcinoma
IL-18, CXCL-8 and CXCL-10 plasma levels decrease in patients with chronic Hepatitis C virus infection undergoing DAA therapy
Follicular T helper cells in patients with cholestatic liver disease – a comparative study
The ALBI score: a new tool for decision making after TACE

Bhadra, OD

HBV infection alters the transcriptional regulation of FXR-dependent microRNAs

Bieback, K

Bone morphogenetic protein (BMP)-9 enhances high glucose-mediated microvascular damage

Bieghs, V

Role of NLRP3 inflammasome activation during cholestatic liver injury
Differential role of NLRP3 inflammasome during acute and chronic cholestatic liver injury

Bierwolf, J

Lack of NKp80 expression define a liver-resident CD49a(+) NK cell subset with ILC1-like features

Binder, B

Sustained Vd1 and Vd2 T-cell profiles in chronic viral hepatitis

Björkström, NK

Characterization of T cell responses after stopping HBV therapy with nucleos(t)ide analogues (NA) in HBeAg-negative patients
NK cell responses during direct-acting antiviral treatment of chronic hepatitis C virus infection

Blahova, M

Major Histocompatibility Complex (MHC) Class I-associated phosphopeptides as potential targets for immunotherapy in hepatocellular carcinoma (HCC)

Bley, T

Short term effect of transarterial chemoembolization (TACE) on microsomal liver function by means of 13C-methacetin breath test (MBT) in patients with hepatocellular carcinoma (HCC)

Blomeyer, S

Evaluation eines Faktor XIII-Mangels mittels Rotationsthrombelastometrie (ROTEM®) bei Leberzirrhosepatienten mit Blutungsneigung

Bock, B

Serum Cell Death Biomarker Mirrors Liver Cancer Regression after Transarterial Chemoembolisation

Bock, H

Detection of a genetic footprint of the sofosbuvir resistance-associated substitution S282T after HCV treatment failure

Bockisch, A

Predictors of Longer Survival after Radioembolization in Unilobar and Bilobar Advanced Hepatocellular Carcinoma with Yttrium-90
C-Reactive Protein the Best Survival Predictor in 100 HCCs with Portal Vein Thrombosis after Radioembolization with Yttrium-90

Bode, JG

IL-1β induced activation of the p38MAPK/MK2 pathway in hepatocytes and macrophages: a mathematical model of cell-type-specific signal transduction
Influence of hepatocytes on macrophage differentiation

Boettler, T

Follicular T helper cells in patients with cholestatic liver disease – a comparative study
Presence of the MBOAT7 rs641738 variant might enhance liver fibrosis in patients with fatty liver: analysis of the German NAFLD CSG cohort

Bohle, RM

Extracorporeal blood purification improves nasobiliary drainage (NBD)-refractory pruritus in a BRIC type 2 patient

Böhm, S

Association of Toll-like receptor 4 (TLR4) gene polymorphisms with remission of chronic hepatitis B infections in female patients

Bolch, M

Combined Photodynamic Therapy with Systemic Chemotherapy Compared to Chemotherapy or Photodynamic Therapy Alone in Patients with Non-Resectable Extrahepatic Cholangiocarcinoma: a Retrospective Study

Borkham-Kamphorst, E

Lipocalin 2 (LCN2)-deficient mice are more prone to hepatic steatosis: LCN2 and mitochondrial and peroxisomal integrity
The CYR61/CTGF/NOV (CCN) family members induce endoplasmic reticulum stress and unfolded protein response
Untersuchung von Lipocalin 2 und Perilipin 5 in der Fruktose-induzierten Nichtalkoholischen Fettlebererkrankung

Borzacov, LMP

Diversity of clinical presentation and virological characteristics of hepatitis delta: The hepatitis Delta International network (HDIN)

Bosserhoff, A

Tumorsuppressive MicroRNA-188-5p Reveals Novel Oncogenes for Hepatocellular Carcinoma

Bosserhoff, AK

Analysis of molecular mechanisms of 5-fluorouracil-induced hepatic steatosis and inflammation in vitro and in mice
Xanthohumol, a prenylated chalcone derived from hops (Humulus lupulus), inhibits hepatic metastasis

Bousset, K

Loss of APC/CDH1 confers sensitivity to synthetic endoplasmatic reticulum stress through the dysregulation of GADD34

Bovensiepen, CS

The Involvement of Tumor Necrosis Factor α in Autoimmune Hepatitis

Bowe, A

Expression of the oncofetal marker Nope in the regenerating adult murine liver after disruption of interhepatocytic gap junctions via bile duct ligation

Bozko, P

Role of Fbxw5 in the induction of centrosome abnormalities and liver tumor formation

Brain, J

Anti-fibrotic and anti-inflammatory consequences of TGF-β2 silencing in biliary liver disease

Brandenburg, M

A non-invasive comparison between NASH and Crohn's disease

Breitkopf-Heinlein, K

Bone morphogenetic protein (BMP)-9 enhances high glucose-mediated microvascular damage

Bretag, T

Multizentrische Studie zur Leberbeteiligung beim Alpha1-Antitrypsin-Mangel

Breuhahn, K

Guanine monophosphate synthetase (GMPS) is an important target of p53-mediated repression in liver cancer
Tumor suppressor genes SORBS3 and SH2D4A collaborate to repress IL-6/STAT3 signaling in hepatocellular carcinoma
Distinct transcriptome and secretome patterns characterize capillarization in early and late phases of hepatocarcinogenesis

Briones, MA

Thyroid Hormone Receptor (TR): a regulator in Liver Fibrogenesis

Broering, R

Hepatitis B virus activates toll-like receptor 2 signaling in primary human hepatocytes
Hepatic expression of oncogenes Bmi1 and Dkk1 is up-regulated in hepatitis B virus surface antigen-transgenic mice in vivo and can be induced by treatment with HBV particles or lipopolysaccharides in vitro

Bröring, R

Kaltlagerung und Kryokonservierung primärer humaner Hepatozyten in modifizierter TiProtec®-Lösung

Bruckner, T

Carcinogenic Etheno DNA-Adducts in Alcoholic Liver Disease: Correlation with Cytochrome P-450 and Fibrosis

Brückner, S

Mesenchymale Stammzellen vermindern die durch Diethylnitrosamin induzierte Entstehung prä-neoplastischer Foci in der Mausleber
Verbesserung der Leberfunktion durch mesenchymale Stammzellen im Mausmodell des Alpha-1-Antitrypsinmangels
Charakterisierung der Akut-Phase Reaktion in humanen Lebergewebekulturen mittels transkriptomweiter Expressionsanalysen

Bruns, T

A TLR9 promoter polymorphism modulates the monocytic immune responses in decompensated cirrhosis
The regulation of inflammasome components in monocytes and macrophages from patients with decompensated cirrhosis

Buchmann, B

Identification of host cell requirements and antivrial targets for hepatitis D virus infection

Büchter, M

ERCP in critically ill patients unit is a safe procedure and does not increase mortality

Buechter, M

Improvement of IgG4-associated autoimmune cholangitis in a patient with HCV-cirrhosis by treatment with sofosbuvir and ledipasvir: a case report

Buettner, R

The Epigenetic Modifications by the Histone Demethylase LSD1 in Hepatic Stellate Cells Contribute to Liver Fibrosis

Buggisch, P

First time use of PRISM, an easy to use and suitable tool to characterize burden of disease, in patients suffering from chronic Hepatitis C: Results from the German observational study LIFE-C
Real-world evidence on all-oral, interferon-free regimens with Ombitasvir/Paritaprevir/r and Dasabuvir for treatment of chronic HCV patients with renal insufficiency in the German Hepatitis C-Registry
Real-world evidence on all-oral, interferon-free regimens with Ombitasvir/Paritaprevir/r and Dasabuvir for treatment of chronic HCV patients receiving opioid substitution therapy in the German Hepatitis C-Registry

Bürger, L

The liver regeneration associated factor ALR attenuates IL-6 induced acute-phase reactants during hepatic inflammation

Buti, M

Diversity of clinical presentation and virological characteristics of hepatitis delta: The hepatitis Delta International network (HDIN)

Büttner, N

Major Histocompatibility Complex (MHC) Class I-associated phosphopeptides as potential targets for immunotherapy in hepatocellular carcinoma (HCC)

Büttner, R

Tumor suppressor microRNA-198 is actively transported out of liver cancer cells